Sophia Genetics SA (SOPH) Stock Forecast & Price Target
Sophia Genetics SA · NASDAQ
$5.58-0.07 (-1.15%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Sophia Genetics SA, 3 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets span $7.00 to $12.00, a moderate spread. The average target of $9.00 sits 61% above the current $5.58. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 2 to 3 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.19 next quarter toward $-0.56 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Strong Buy
Strong Buy00%
Buy3100%
Hold00%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to Sophia Genetics SA.
As of Jul, 3 of 3 firms rate SOPH a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
SOPH EPS & revenue forecast
EPS · NEXT QUARTER
$-0.19
Range $-0.19 – $-0.19 · 1 analysts · -3% YoY
Next period, 1 analysts expect Sophia Genetics SA to earn $-0.19 a share (range $-0.19 – $-0.19), versus $-0.20 a year earlier. Full-year consensus is $-0.78, growing to $-0.56 the year after.
REVENUE · NEXT QUARTER
$23.8M
Range $22.9M – $24.5M · 1 analysts · +22% YoY
Revenue is expected to reach $23.8M (range $22.9M – $24.5M), +22.3% year-over-year. Full-year consensus is $93.4M, rising to $114.6M next year.
Top analysts covering Sophia Genetics SA
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on SOPH.
#1
Swayampakula Ramakanth
HC Wainwright & Co. · Rank #230
Buy
$12.00+114.9% to target
Overall win rate
37%
+ Follow
#2
Conor McNamara
RBC Capital · Rank #349
Buy
$7.00+25.3% to target
Overall win rate
25%
+ Follow
#3
Mark Massaro
BTIG
Buy
$8.00+43.2% to target
Coverage
—
+ Follow
#4
TS
Tejas Savant
Morgan Stanley
Hold
$5.00-10.5% to target
Coverage
—
+ Follow
#5
Daniel Brennan
TD Cowen
Buy
No targeton SOPH
Coverage
—
+ Follow
SOPH stock forecast FAQ
What is SOPH's average 12-month price target?+
The 3 analysts with a live target average $9.00 for Sophia Genetics SA over the next 12 months, ranging from a $12.00 high to a $7.00 low.
Is SOPH stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 3 analyst ratings, 3 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for SOPH?+
The Street-high target is $12.00 (HC Wainwright & Co.), and the Street-low is $7.00 (Guggenheim). The average of all 3 active targets is $9.00.
How many Wall Street analysts cover SOPH?+
3 analysts have an active rating on Sophia Genetics SA, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering SOPH?+
Among analysts who currently cover SOPH, Swayampakula Ramakanth of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #230). Their current call is Buy with a $12.00 target.
What is Sophia Genetics SA's projected EPS for next quarter?+
The consensus estimate is $-0.19 per share (range $-0.19 – $-0.19) across 1 analysts. Full-year EPS is projected at $-0.78, rising to $-0.56 the following year.
How much revenue is Sophia Genetics SA expected to report next quarter?+
Consensus revenue is $23.8M (range $22.9M – $24.5M). Full-year revenue is projected at $93.4M, growing to $114.6M next year.
Have analysts been upgrading or downgrading SOPH lately?+
As of Jul, 3 of 3 firms rate SOPH a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their SOPH calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
